Media
Teewinot Life Sciences In the News
October 17, 2019 Teewinot Announces Availability of Cannabinol for Commercial Cannabinoid Market
September 10, 2019 Pharma’s Almanac Highlights Teewinot’s CannSynthesis® Platform And The Benefits Of Biosynthetic Cannabinoids
September 4, 2019 Teewinot Life Sciences Expands First In Class Intellectual Property Portfolio
July 25, 2019 Teewinot CEO Michael Luther Interviewed on Daniel Levine’s “The Bio Report”
July 6, 2019 Teewinot CEO Michael Luther Highlighted in Marijuana Business Magazine “Industry Players”
May 22, 2019 Teewinot Life Sciences Announces Executive Leadership Changes
September 4, 2018 Teewinot Life Sciences Corporation Announced Today Grant Of A Canadian Patent With Broad Claims To Biosynthetic Production Of Cannabinoids
August 28, 2018 Teewinot Life Sciences Corporation Announced Today Grant of a U.S. Patent with Claims to Cannabinoid Formulations
February 8, 2018 Teewinot collects patents to make cannabinoids in US and Ireland
February 6, 2018 NetworkNewsAudio – Teewinot Life Sciences Corporation Interview
November 27, 2017 Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical Cannabinoid Production, to Present at CBI’s Biopharma Forum on Cannabis-Based Therapies
November 15, 2017 ALGAE DYNAMICS CORP SECURES US $250,000 INVESTMENT FROM TEEWINOT LIFE SCIENCES CORPORATION
July 11, 2017 Teewinot Life Sciences Corporation in the Tampa Bay Times, “One day, the Tampa Bay area will land its Chewy”
June 17, 2017 Teewinot Life Sciences Corporation’s Jeff Korentur in The Medicine Maker, “A View From the Biosynthetic Bridge”
June 2, 2017 Teewinot Life Sciences Corporation in PharmaTech, “Accessing Cannabinoids Using Biocatalysis”
May 22, 2017 Teewinot Life Sciences Corporation Announces New Cannabis Genome Research Program
March 20, 2017 Teewinot Life Sciences and Noramco sign letter of intent to produce cannabinoids with CannSynthesis™ biocatalysis technology
February 22, 2017 Teewinot Life Sciences in CBInsights, “Grapeless Wine And Cowless Milk: 60+ Synthetic Biology Startups In A Market Map”
February 16, 2017 Teewinot Life Sciences in Outsourcing-Pharma, “Teewinot ups cannabinoid production capabilities”
February 14, 2017 Teewinot Life Sciences in PRN, “Teewinot Life Sciences Corporation Announces Breakthrough Commercial Production of the Cannabinoid Varin Series”
February 8, 2017 CEO, Jeffrey Korentur, quoted in in-Pharma, “Pot luck? Medical marijuana’s ‘questionable quality’ no threat to pharma R&D”
January 5, 2017 Patented biosynthesis produces ‘authentic, standardized cannabinoids’ for pharma
January 3, 2017 Teewinot Life Sciences’ Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures a New U.S. Patent for Biosynthesis of Cannabinoids
December 18, 2016 Teewinot Life Sciences CEO, Jeffrey Korentur, quoted in Indie Sources, “How Medical Marijuana May Be Moving More Toward Actual Medicine”
November 28, 2016 Teewinot Life Sciences President, Robert Hunt, interviewed in Health Business Blog, “Recreational marijuana is becoming legal. How will the laws be implemented?”
November 16, 2016 Teewinot Life Sciences CEO, Jeffrey Korentur, interviewed in Pharmaceutical Processing, “Cannabinoid-Based Therapies Find a Home in the Pharma Industry”
November 9, 2016 Teewinot Life Sciences President, Robert Hunt, quoted in Forbes, “More States Legalize Marijuana, But Will President Trump Allow It?”
November 8, 2016 Teewinot Life Sciences President, Robert Hunt, quoted on Fox Business, “Marijuana Vote is Big Money This Election”
November 7, 2016 Teewinot Life Sciences President, Robert Hunt, quoted in Forbes discussing “Could California’s Marijuana Law Affect The Entire Country?”
November 5, 2016 Teewinot Life Sciences mentioned in Wired article, “Want Your Marijuana Startup to Succeed? Study Patent Law”, for its patents
November 3, 2016 Teewinot Life Sciences President, Robert Hunt, quoted in volteface discussing November’s legalization’s watershed moment
November 1, 2016 Teewinot Life Sciences CEO, Jeffrey Korentur, quoted in Playboy article, “Can Medical and Recreational Weed Coexist?”
October 19, 2016 Teewinot Life Sciences President, Robert Hunt, quoted in Inc., “New Gallup Survey Finds 60 Percent of Adults Support Legal Marijuana Use”
October 18, 2016 Teewinot Life Sciences to present at the prestigious BIO Investor Forum in San Francisco
October 17, 2016 Teewinot Life Sciences President, Robert Hunt, quoted in Forbes discussing Marijuana On The Ballot: State By State Opportunities For Entrepreneurs
October 6, 2016 Teewinot Life Sciences President, Robert Hunt, to present and moderate at the Global Alpha Forum in Stamford, CT
September 15, 2016 Teewinot Life Sciences President, Robert Hunt, is interviewed by WHCU radio in Ithica, NY
August 15, 2016 Teewinot Life Sciences President, Robert Hunt, interviewed on the CBS Radio show All Business with Jeffrey Hayzlett
August 11, 2016 Teewinot Life Sciences President, Robert Hunt, quoted in MarketWatch discussing the DEA announcement related to cannabis and cannabinoids
August 2, 2016 Teewinot Life Sciences discussed in a story in Privcap, a global authority on the Private Equity industry
June 16, 2016 Tuatara Capital Leadership Interviewed by The Street at the Cannabis World Congress
March 8, 2016 Global Leader In Pharmaceutical Cannabinoid Production Secures $7 Million With Tuatara Capital Leading The Series A Round
March 4, 2016 Teewinot Life Sciences President, Robert Hunt, discussing the how true pharmaceutical based cannabinoid based medicines will be replacing medical cannabis as we know it today (Use password: 420)
Media Relations Contact
Contact: Kellen Murphy – CIO
Email: kellen@tlscorp.com
Number: (813) 607-2909